TrialThoracic cancer2019

The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute.

Kei Sonehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.